Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05061316 · ClinicalTrials.gov registry record · NA
The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery
A NA study of Cancer of Head and Neck and Nutrition Aspect of Cancer, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05061316: Completed NA study of Cancer of Head and Neck and Nutrition Aspect of Cancer, sponsored by University of Alabama at Birmingham.
NCT05061316 is a NA study of Cancer of Head and Neck and Nutrition Aspect of Cancer that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants, below the 247-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05061316, a NA study of Cancer of Head and Neck and Nutrition Aspect of Cancer, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how a pre-operative nutritional intervention alters the gut microbiome and improves outcomes after major head and neck cancer surgery.
Primary Outcome
Stool samples will be collected prior to the nutrition intervention and after completing 5 days of intervention. Stool samples will be processed and sequenced for 16S microbiome analysis. The composition of the gut microbiome will be compared before and after the immunonutrition intervention.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Nestlé Impact Advanced Recovery
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-11 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
What the finished NCT05061316 record still lists
NCT05061316 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 247-participant average among 9 other Cancer of Head and Neck trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Cancer of Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which Nestlé Impact Advanced Recovery is the first listed.
NCT05061316 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05061316 about?
NCT05061316 is a clinical study titled "The Gut Microbiome As an Indicator of Readiness for Head & Neck Cancer Surgery". The purpose of this study is to understand how a pre-operative nutritional intervention alters the gut microbiome and improves outcomes after major head and neck cancer surgery.
What is the current status of trial NCT05061316?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-11. Estimated completion is 2025-02-01.
What conditions does trial NCT05061316 study?
This clinical trial studies the following conditions: Cancer of Head and Neck, Nutrition Aspect of Cancer.
What interventions are being tested in trial NCT05061316?
The interventions under investigation include: Nestlé Impact Advanced Recovery (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05061316?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05061316 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer of Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05061316's enrollment target sits among peer trials
20 5th of 9 higher than 5 of 9 other Cancer of Head and Neck trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer of Head and Neck trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Comprehensive Approach to Head and Neck Cancer Prehabilitation
ACTIVE NOT RECRUITING · NA
-
Onco-primary Care Networking to Support TEAM-based Care
ACTIVE NOT RECRUITING · NA
-
Adaptive Radiation Therapy for Head & Neck Cancer Patients
COMPLETED · NA
-
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers
COMPLETED · NA
-
Single-arm Phase II Study of NDURE for Patients With HNC
COMPLETED · NA
-
A Multicenter Cancer Biospecimen Collection Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI